What are the expected lab values for estradiol (E2) and testosterone in perimenopausal women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Expected Laboratory Values for Perimenopause: Estradiol and Testosterone

The expected laboratory values for perimenopausal women include estradiol levels ranging from 13.1-135 ng/mg creatinine (or approximately 54.6-2,050.5 pmol/L), which is significantly higher than postmenopausal values but with greater variability than in regular cycling women.

Perimenopause Hormonal Profile

Estradiol (E2)

  • Normal range in perimenopause:
    • 13.1-135 ng/mg creatinine (urinary) 1
    • Approximately 54.6-2,050.5 pmol/L (serum) 2
  • This represents a wide range with substantial interindividual variation
  • Higher than postmenopausal levels (typically 9-12 pg/mL) 3
  • Often fluctuates significantly during perimenopause
  • May be elevated compared to younger reproductive-aged women (mean 76.9 ng/mg creatinine vs 40.7 ng/mg creatinine) 1

Testosterone

  • Normal range in perimenopause: Approximately 19.9-26.2 ng/dL (total testosterone)
  • Free testosterone: Approximately 3.7-4.6 pg/mL 3
  • Testosterone levels tend to gradually increase with age through perimenopause and into postmenopause
  • Single measurements are generally reliable (intraclass correlation coefficient of 0.92) 4

Hormonal Changes in Perimenopause

Characteristic Patterns

  • Follicular phase shortening: 11±2 days vs 14±1 days in younger women 1
  • Elevated FSH: 4-32 IU/g creatinine (higher than reproductive age but lower than postmenopause) 1
  • Elevated LH: 1.4-6.8 IU/g creatinine (higher than reproductive age but lower than postmenopause) 1
  • Decreased luteal phase progesterone: Reduced pregnanediol excretion compared to younger women 1

Clinical Implications

  • Hyperestrogenism is common in perimenopause
  • Hypergonadotropism (elevated FSH/LH) occurs despite continued estrogen production
  • Decreased progesterone production in luteal phase
  • These hormonal alterations contribute to increased gynecological symptoms during perimenopause 1

Factors Affecting Hormone Levels

Several factors can influence hormone levels during perimenopause:

  • Body Mass Index (BMI): Higher BMI is associated with higher estradiol levels 5
  • Alcohol use: Associated with higher estradiol levels 5
  • Smoking: Current and past smoking associated with lower estradiol levels 5
  • Age: Hormone variability is greater in younger perimenopausal women 2
  • Medication use: Some medications (e.g., antihypertensives) may affect estradiol levels 5

Important Considerations for Laboratory Testing

  • Laboratory values should be interpreted in the context of clinical symptoms
  • Significant day-to-day variability occurs during perimenopause
  • Multiple measurements may be needed for accurate assessment
  • Estrone levels may be more reliably measured than estradiol in some cases 4
  • Morning samples are preferred for consistency

Comparison with Other Reproductive Stages

Hormone Perimenopause Postmenopause Reproductive Age
Estradiol 13.1-135 ng/mg Cr 2.5-6.2 ng/mg Cr 22.8-60.3 ng/mg Cr
FSH 4-32 IU/g Cr 24-85 IU/g Cr 3-7 IU/g Cr
LH 1.4-6.8 IU/g Cr 4.3-14.8 IU/g Cr 1.1-4.2 IU/g Cr

The perimenopause represents a unique hormonal state characterized by fluctuating but often elevated estradiol levels, rising gonadotropins, and decreased progesterone production. Laboratory values during this transitional period show wide variability and should be interpreted with consideration of the patient's clinical presentation and symptoms.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.